NCT05740202 A Trial of SHR-7367 in Subjects With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05731934 The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05731752 Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05719558 A Study of ASP1002 in Adults for Treatment of Solid Tumors Status RECRUITING Phase PHASE1
NCT05718219 Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05701709 Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05688605 A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT05678283 A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors Status WITHDRAWN Phase PHASE1
NCT05649761 A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT05625412 A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05620017 Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection Status RECRUITING Phase PHASE1
NCT05614102 A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05609019 A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT05605496 NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05599984 Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05593094 A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05592626 A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2